CASP3 and ovarian cancer: Interestingly, compared to GO, UA-rGO showed significant dose-dependent cytotoxicity in A2780 ovarian cancer cells by reducing cell viability, increasing release of LDH, generating ROS, activating caspase-3, and DNA fragmentation.